During the past decade, St. Luke's Cancer Care Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Luke's Cancer Care Associates" are "BRAF or NRAS Mutant Metastatic Melanoma" (1 trials), "Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "St. Luke's Cancer Care Associates" in a lesser frequency.

Most popular intervention types in "St. Luke's Cancer Care Associates" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Nab-Paclitaxel" (2 trials), "Paclitaxel" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Cancer Care Associates" are 7 trials for "All" genders.

Currently, there are NaN active trials in "St. Luke's Cancer Care Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in St. Luke's Cancer Care Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Cancer Care Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".